Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages
- PMID: 2476959
- DOI: 10.1164/ajrccm/140.3.771
Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages
Abstract
We studied the permissiveness of human leukocytes, blood monocytes, alveolar macrophages, and cord blood monocytes to infection with respiratory syncytial virus (RSV). Specific immunofluorescence was used to determine the percentage of infected leukocytes. The results indicated that monocytes were the most susceptible human leukocyte to in vitro infection with RSV. Polymorphonuclear leukocytes demonstrated no specific fluorescent staining after 24 h of exposure to RSV, whereas peripheral blood nonadherent mononuclear cells demonstrated a low percentage of positive cells, with a mean of 6 +/- 1% SE. In contrast, 37 +/- 5% of monocytes expressed RSV antigen after viral exposure. Exposure of monocytes to lipopolysaccharide (LPS) for 1 h prior to RSV increased the percentage of infected cells to 48 +/- 6% and stimulated their secretion of prostaglandin E2 (PGE2) and alpha tumor necrosis factor (TNF). Intrinsic mononuclear phagocytic factors influencing the permissiveness to RSV were studied by determining infection of adult and cord blood and alveolar mononuclear phagocytes (MP). Alveolar and blood MP simultaneously isolated from adult donors were similarly infected by RSV, which varied with the viral dose. Cord blood MP were more susceptible to RSV infection than were adult MP, 58 +/- 9% infected versus 37 +/- 5%, respectively (p less than 0.05). Treatment with LPS for 1 h prior to RSV exposure did not increase infection of cord blood MP as seen with adult blood MP. However, LPS can induce human monocytes to secrete cytokines with antiviral activity, and our results indicate that both gamma interferon and TNF, independently or in combination, prevented infection of monocytes in a dose-dependent manner.
Similar articles
-
Virus-induced alterations in macrophage production of tumor necrosis factor and prostaglandin E2.Am J Physiol. 1990 Dec;259(6 Pt 1):L396-402. doi: 10.1152/ajplung.1990.259.6.L396. Am J Physiol. 1990. PMID: 2260674
-
Productive infection of isolated human alveolar macrophages by respiratory syncytial virus.J Clin Invest. 1990 Jul;86(1):113-9. doi: 10.1172/JCI114672. J Clin Invest. 1990. PMID: 2365811 Free PMC article.
-
Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro.J Immunol. 1995 Jan 1;154(1):268-80. J Immunol. 1995. PMID: 7995946
-
Ozone effect on respiratory syncytial virus infectivity and cytokine production by human alveolar macrophages.Environ Res. 1993 Feb;60(2):178-86. doi: 10.1006/enrs.1993.1025. Environ Res. 1993. PMID: 8472647
-
Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages.Am J Respir Cell Mol Biol. 2000 Nov;23(5):586-92. doi: 10.1165/ajrcmb.23.5.3771. Am J Respir Cell Mol Biol. 2000. PMID: 11062136
Cited by
-
The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response.Int J Mol Sci. 2024 Sep 11;25(18):9800. doi: 10.3390/ijms25189800. Int J Mol Sci. 2024. PMID: 39337288 Free PMC article. Review.
-
Neutralizing and enhancing activities of human respiratory syncytial virus-specific antibodies.Clin Diagn Lab Immunol. 1996 May;3(3):280-6. doi: 10.1128/cdli.3.3.280-286.1996. Clin Diagn Lab Immunol. 1996. PMID: 8705669 Free PMC article.
-
Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection.PLoS One. 2012;7(7):e40499. doi: 10.1371/journal.pone.0040499. Epub 2012 Jul 6. PLoS One. 2012. PMID: 22792355 Free PMC article.
-
The role of respiratory syncytial virus G protein in immune cell infection and pathogenesis.EBioMedicine. 2024 Sep;107:105318. doi: 10.1016/j.ebiom.2024.105318. Epub 2024 Aug 31. EBioMedicine. 2024. PMID: 39217853 Free PMC article. Review.
-
Increased number of T cells committed to IL-5 production after respiratory syncytial virus (RSV) infection of human mononuclear cells in vitro.Clin Exp Immunol. 1998 Sep;113(3):450-5. doi: 10.1046/j.1365-2249.1998.00683.x. Clin Exp Immunol. 1998. PMID: 9737676 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources